We explored the potential impact of HPV testing on women’s intentions to be screened for cervical cancer in a cohort of Canadian women. Participants aged 25-65 from an ongoing trial were sent a questionnaire to assess women’s intentions to be screened for cervical cancer with HPV testing instead of Pap smears and to be screened every 4 years or after 25 years of age. We created scales for attitudes about HPV testing, perceived behavioural control and direct and indirect subjective norms. Demographic data and scales that were significantly different (p<0.1) between women who intended to be screened with HPV and those who did not intend were included in a stepwise logistic regression model. Of the 2016 invitations emailed, 1538 were received,...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of human papillomavirus (HPV) testing on women's intentions to be s...
Cervical cancer screening and prevention has been one of the great success stories in public health,...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screeni...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screen...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervic...
Human papillomavirus (HPV) testing is recommended for primary screening for cervical cancer by sever...
Abstract Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cance...
Cervical cancer screening guidelines in the United States were revised in 2018 to include the option...
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, an...
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, an...
Background Primary HPV cervical screening is due to be implemented in England within the next 2 yea...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of human papillomavirus (HPV) testing on women's intentions to be s...
Cervical cancer screening and prevention has been one of the great success stories in public health,...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screeni...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screen...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervic...
Human papillomavirus (HPV) testing is recommended for primary screening for cervical cancer by sever...
Abstract Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cance...
Cervical cancer screening guidelines in the United States were revised in 2018 to include the option...
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, an...
Background: Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, an...
Background Primary HPV cervical screening is due to be implemented in England within the next 2 yea...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...